Surinder Thakur

• Understanding important stakes in key accounts and enhancing mutual partnership to improve patient access to Roche products.

Highlights

• Achieved highest number of new enrolments for new launches ie Polivy and Rozlytrek in cluster for 2024.
• Awarded Roche’s most prestigious CEO award for exemplary performance in 2023.
• Recognized as one of the top achievers for two focus brands under Excellence League Awards for 2023.
• Recruited for Nagpur headquarter in March-2022 and shifted to Mumbai after turn-around performance in six months.

• Adaptation of new role and responsibility by quick learning, thereby leading team towards a quantifiable and stretched goals in 2018
• Driving and motivating team to ensure right balance within diversified team and delivering 90% in 2019
• Adjudicated to be a core member of Compliance Champions since 2019
• Utilizing and practicing people skills to retain team and avoid attritions, also dealing the team with empathy to face COVID phase in a resilient manner and achieving 77% in 2020.

• Achieved >115% of 2017 primary budget and qualified for Annual Award trip to Bali.
• Achieved >118% of 2016 primary budget & 140% of secondary budget in 2016.
• Achieved >100% of primary budget & 107% of secondary budget in 2015.

• Achieved >100% of achievement for focus products consecutively in 2008/2009/2010/2011/2012/2013/2014.
• Qualified for ASAF as Superstar with 110% performance in 2009 held at Dubai
• Achieved Annual Brand Awards for Femara/Zometa/Sandostatin LAR/Afinitor
• Achieved annual award for NCSM model & recognized by nomination in Global Training Workshop at Singapore
• Established Novartis Oncology in Goa and ensured double digit growth year after year.
• Part of Zone of the year team in 2013.